A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia

Protocol No
ALLIANCE-A222004-ANOREXIA
Principal Investigator
Aditya Shreenivas
Phase
III
Summary
We are asking you to take part in this research study because your cancer and treatments for your cancer can cause side effects such as loss of appetite. This study is looking at the effect of olanzapine on your appetite and weight loss.
Description
Olanzapine vs Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Participating Institutions
Drexel Town Center
Froedtert Menomonee Falls Hospital
Froedtert West Bend Hospital
Froedtert Hospital
Status
OPEN TO ACCRUAL